Sign in

danielevanbauer.bsky.social

@danielevanbauer.bsky.social
58 followers 126 following 10 posts
PostsRepliesMedia
danielevanbauer.bsky.social @danielevanbauer.bsky.social · 25/09/2026
IGF2BP1 revealed as a double agent* hemoglobin switcher! How this heterochronic RBP both inhibits BCL11A (thru HIC2) & directly binds + supports the fetal globin transcript: ashpublications.org/blood/articl... Led by fantastic Steve Coyne. *Scott Peslak blurb: ashpublications.org/blood/articl...
ashpublications.org
Direct and indirect regulation of fetal globin transcript by the RNA-binding protein IGF2BP1
Key PointsThe RBP regulates fetal hemoglobin directly through posttranscriptional control and indirectly via BCL11A.IGF2BP1 binding to a stop codon–proxima
020
danielevanbauer.bsky.social @danielevanbauer.bsky.social · 16/09/2026
Inspired by Gibson cloning, we describe prime assembly, now published, for in cellulo targeted integration of gene-sized DNA fragments using prime editing. www.nature.com/articles/s41...
163
danielevanbauer.bsky.social @danielevanbauer.bsky.social · 27/03/2026
In this piece, my mentor Stu Orkin and I (1) marvel at prime editing—discovery to disease correction for 2 patients after just 6 yr—wow Liu, Anzalone, Gori, Malech et al! & (2) consider the challenges to deliver genetic medicine’s promise for 2^n patients www.nejm.org/doi/full/10....
nejm.org
Genetic Medicine — Primed and Ready | NEJM
Immunodeficiency chronic granulomatous disease (CGD) is a rare disorder characterized by defects in a multiprotein complex that generates superoxide in phagocytic cells.1 Recurrent infections and f...
010
danielevanbauer.bsky.social @danielevanbauer.bsky.social · 15/07/2025
@sebastien-levesque.bsky.social and I review therapeutic genome editing for inherited blood disorders rdcu.be/ewcZ3. We cover CRISPR, patient journey, DNA repair, patient access, genotoxicity, hemoglobinopathies, delivery, bone marrow failure, coselection, immunodeficiency, and more.
rdcu.be
CRISPR-based therapeutic genome editing for inherited blood disorders
Nature Reviews Drug Discovery - CRISPR-based technologies provide a diverse set of tools to correct pathogenic mutations. This Review describes the promise and the challenges of genome editing...
120
danielevanbauer.bsky.social @danielevanbauer.bsky.social · 18/06/2025
Excited to share our latest where we describe a gene editing method termed prime assembly that enables RNA programmable targeted integration of gene-sized DNA sequences in nondividing cells without dsDNA or nuclease-driven DSBs. See thread by incomparable @Seb. Also complementary work Sontheimer/Xue
041
Reposted by @danielevanbauer.bsky.social
Ben Kleinstiver @bkleinstiver.bsky.social · 22/04/2025
In @nature.com we describe the use of scalable #proteinengineering & #machinelearning to predict millions of bespoke CRISPR enzymes, offering safer & more efficient genome editing tools 🧬🖥️ @rachelsilverstein9.bsky.social @mgbresearch.bsky.social @harvardmed.bsky.social www.nature.com/articles/s41...
nature.com
Custom CRISPR—Cas9 PAM variants via scalable engineering and machine learning - Nature
Nature - Custom CRISPR—Cas9 PAM variants via scalable engineering and machine learning
35121
Reposted by @danielevanbauer.bsky.social
Jennifer Trowbridge @trowbridgelab.bsky.social · 16/04/2025
New paper from my lab! Elevated mitochondrial membrane potential is a therapeutic vulnerability in Dnmt3a-mutant clonal hematopoiesis: rdcu.be/eh1Nb Complementary to new work from Steven Chan & @georgevassiliou.bsky.social as described by @goodell-lab.bsky.social: www.nature.com/articles/d41...
nature.com
Age-related blood condition counteracted with a common diabetes drug
Metformin could reduce people’s risk of certain age-associated blood cancers, but more work is needed to identify who is likely to benefit.
15011
Reposted by @danielevanbauer.bsky.social
Eric Topol @erictopol.bsky.social · 01/03/2025
Francis Collins, the NIH Director for 12 years, led the Human Genome Project and other NIH efforts for 32 years, resigned today. Key words from his resignation letter www.nytimes.com/2025/03/01/u...
6131251381